We are live on
!
Find out more
NCGI
Next Century Growth Investors Portfolio holdings
AUM
$1.38B
1-Year Est. Return
102.34%
This Fund
S&P 500
This Quarter
Est. Return
+5.68%
1 Year Est. Return
+102.34%
3 Year Est. Return
+305.75%
5 Year Est. Return
+498.06%
10 Year Est. Return
+7,120.12%
AUM
$1.11B
AUM Growth
-$43.1M
(-3.7%)
Cap. Flow
-$65M
Cap. Flow
% of AUM
-5.84%
Top 10 Holdings %
Top 10 Hldgs %
26.69%
Holding
137
New
8
Increased
32
Reduced
77
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xometry
XMTR
|
+$25.3M |
| 2 |
Lantheus
LNTH
|
+$14.4M |
| 3 |
Arteris
AIP
|
+$13.1M |
| 4 |
CS Disco
LAW
|
+$10.3M |
| 5 |
Treace Medical Concepts
TMCI
|
+$9.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SiTime
SITM
|
+$34.6M |
| 2 |
OptimizeRx
OPRX
|
+$23M |
| 3 |
HealthEquity
HQY
|
+$11.8M |
| 4 |
ACCD
Accolade Inc
ACCD
|
+$9.76M |
| 5 |
SI
Silvergate Capital Corporation
SI
|
+$8.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.18% |
| 2 | Technology | 28.86% |
| 3 | Industrials | 16.33% |
| 4 | Financials | 12.38% |
| 5 | Consumer Discretionary | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Lattice Semiconductor
LSCC
$18.7B
| $13.8M | 1.25% |
179,640
-47,558
| -21% | -$3.53M |
|
27
SI-BONE Inc
SIBN
$851M
| $13.6M | 1.23% |
613,921
+381,371
| +164% | +$8.21M |
|
28
Vericel Corp
VCEL
$2.26B
| $13.6M | 1.22% |
346,225
-48,866
| -12% | -$2.14M |
|
|
SEMR
29
DELISTED
Semrush
SEMR
| $13.3M | 1.2% |
638,950
+321,789
| +101% | +$7.17M |
|
30
Kornit Digital
KRNT
$790M
| $13.2M | 1.19% |
86,710
-13,180
| -13% | -$2.03M |
|
31
Castle Biosciences
CSTL
$998M
| $13.2M | 1.19% |
307,844
+32,402
| +12% | +$1.69M |
|
32
NMI Holdings
NMIH
$3.35B
| $12.9M | 1.16% |
590,814
+47,709
| +9% | +$1.06M |
|
33
Planet Fitness
PLNT
$3.67B
| $12.7M | 1.15% |
140,718
-6,710
| -5% | -$572K |
|
|
TSC
34
DELISTED
TriState Capital Holdings, Inc.
TSC
| $12.7M | 1.14% |
420,115
-7,661
| -2% | -$216K |
|
|
35
CS Disco
LAW
$274M
| $12.7M | 1.14% |
355,501
+231,293
| +186% | +$10.3M |
|
|
36
Arteris
AIP
$1.34B
| $12.2M | 1.1% |
+577,204
| New | +$13.1M |
|
37
Bridgewater Bancshares
BWB
$597M
| $12M | 1.08% |
681,145
-12,614
| -2% | -$226K |
|
38
STAAR Surgical
STAA
$1.25B
| $12M | 1.08% |
131,703
+37,748
| +40% | +$4.05M |
|
39
Celsius Holdings
CELH
$6.71B
| $11.9M | 1.07% |
479,625
-1,707
| -0.4% | -$47.2K |
|
40
Essent Group
ESNT
$6.31B
| $11.7M | 1.05% |
256,686
-12,588
| -5% | -$577K |
|
41
Ryan Specialty Holdings
RYAN
$10.9B
| $11.3M | 1.02% |
281,213
+112,647
| +67% | +$4.27M |
|
42
Microsoft
MSFT
$3.81T
| $11.1M | 1% |
33,002
+4,383
| +15% | +$1.42M |
|
43
Quanta Services
PWR
$101B
| $11M | 0.99% |
96,088
-4,596
| -5% | -$530K |
|
|
44
SiTime
SITM
$22B
| $11M | 0.99% |
37,630
-132,107
| -78% | -$34.6M |
|
45
Allient
ALNT
$1.96B
| $10.6M | 0.96% |
291,005
+21,560
| +8% | +$797K |
|
46
InfuSystem Holdings
INFU
$248M
| $10.3M | 0.93% |
606,884
-254,008
| -30% | -$4.03M |
|
47
Tandem Diabetes Care
TNDM
$1.56B
| $10.2M | 0.92% |
67,572
-3,255
| -5% | -$439K |
|
48
Vicor
VICR
$10.1B
| $9.4M | 0.85% |
74,074
-12,253
| -14% | -$1.73M |
|
49
Marten Transport
MRTN
$1.21B
| $8.9M | 0.8% |
518,785
+66,869
| +15% | +$1.11M |
|
50
Penumbra
PEN
$12.8B
| $8.7M | 0.78% |
30,288
+6,553
| +28% | +$1.73M |
|
Similar funds
JHU
RAM
IC
LWL
RIM
AU
OCAM
SMC
Next Century Growth Investors's Q4 2021 Portfolio in Review
As of Q4 2021, Next Century Growth Investors held 137 positions worth $1.11B, down 3.7% from $1.15B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Next Century Growth Investors withdrew a net $65M in Q4 2021, closing 16 positions and reducing 77 holdings. Its most notable exit was OptimizeRx, an estimated $23M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.
Against the trend, Next Century Growth Investors opened a new position in Arteris worth $12.2M.
- Next Century Growth Investors's largest Q4 2021 buy was Arteris: 577,204 shares worth $12.2M.
- Next Century Growth Investors added most to Xometry in Q4 2021, an estimated $25.3M increase.
- Next Century Growth Investors's biggest Q4 2021 reduction was SiTime, cutting an estimated $34.6M.
- Next Century Growth Investors fully exited OptimizeRx in Q4 2021, selling an estimated $23M.
- Next Century Growth Investors's ten largest holdings make up 27% of its $1.11B portfolio in Q4 2021.
- Next Century Growth Investors opened 8 new positions and closed 16 in Q4 2021.
- Next Century Growth Investors's portfolio value fell 3.7% quarter-over-quarter to $1.11B.
Based on Next Century Growth Investors's 13F filing for Q4 2021, filed 14 Feb 2022.